Randomized Trials in Cardiovascular Imaging
نویسنده
چکیده
A decade ago, cardiovascular imaging was buffeted by a perfect storm of disproportionate growth, unexplained geographic variability, skyrocketing costs, inadequate evidence base, and competition among specialties and modalities. Fortunately, the imaging community and, more broadly, the house of cardiology have appropriately responded to the crisis by fully embracing the concept of value over volume in cardiovascular imaging. As a result, novel initiatives such as appropriate use criteria (first issued in 2005) (1), imaging quality frameworks (promulgated by a series of think tanks in 2005, 2008, and 2015 dedicated to imaging quality [2–4]), subspecialty journals including iJACC and Circulation Cardiovascular Imaging (both launched in 2008) and the European Journal of Cardiovascular Imaging (2011), and close radiology-cardiology collaborations (through such organizations as the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Magnetic Resonance) have become fully accepted parts of the rich fabric of cardiovascular imaging today. The commitment to value in imaging care is also apparent in the explosion of high-quality evidence generated in the past decade regarding the use of cardiovascular imaging. Indeed, 10 years ago, the idea of a special issue of iJACC devoted to randomized controlled trials would not have been possible. The visual nature of imaging provided clinicians and researchers alike
منابع مشابه
Influence of noninvasive cardiovascular imaging in primary prevention: systematic review and meta-analysis of randomized trials.
BACKGROUND Despite extensive use in practice, the impact of noninvasive cardiovascular imaging in primary prevention remains unclear. METHODS We searched for randomized trials that compared imaging with usual care and reported any of the following outcomes in a primary prevention setting: medication prescribing, lifestyle modification (including diet, exercise, or smoking cessation), angiogra...
متن کاملPatient selection for elective revascularization to reduce myocardial infarction and mortality: new lessons from randomized trials, coronary physiology, and statistics.
متن کامل
Computed tomography coronary plaque imaging as a secondary end point for randomized pharmaceutical trials: more bang for the buck?
In a perfect world for the cardiovascular computed tomography (CT) researcher, quantitative assessment of coronary atherosclerotic plaque using CT angiography (CTA) has been validated as a surrogate end point for major cardiovascular events and is used to prove the efficacy and efficiency of new drugs in a very cost-effective manner within a viable framework provided by the US Food and Drug Adm...
متن کاملClinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Radical resection has been considered the only possible way to save the lives of patients with esophageal cancer. Therefore, tremendous efforts have been made in order to improve the surgical results for resectable locoregional esophageal cancer. Various surgical approaches have been developed. Combination therapies such as neoadjuvant, adjuvant chemotherapy, and neoadjuvant chemoradiation have...
متن کاملCoronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial
BACKGROUND The incidence of cardiovascular disease (CVD) in rheumatoid arthritis (RA) is increased compared to the general population. Immune dysregulation and systemic inflammation are thought to be associated with this increased risk. Early diagnosis with immediate treatment and tight control of RA forms a central treatment paradigm. It remains unclear, however, whether using tumor necrosis f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017